Skip to Main Content

Paper Details

The association of phosphodiesterase-5 inhibitors with the biochemical recurrence-free and overall survival of patients with prostate cancer following radical prostatectomy.
Urol Oncol
6
2022
Author NameAffiliation
Borko JovanovicNorthwestern University
Michael GurleyRobert H. Lurie Comprehensive Cancer Center, Northwestern University
Timothy M KuzelRush University Medical Center
  • 1 - 3

Datasets

Release 1.2